首页> 外文期刊>International journal of gynecological cancer: official journal of the International Gynecological Cancer Society >In the November issue (Vol. 29:31) of the Journal of Clinical Oncology, there are two ''comments and controversies''published by our colleagues. Introduction.
【24h】

In the November issue (Vol. 29:31) of the Journal of Clinical Oncology, there are two ''comments and controversies''published by our colleagues. Introduction.

机译:在《临床肿瘤学杂志》 11月号(第29:31卷)中,我们的同事发表了两个“评论和争议”。介绍。

获取原文
获取原文并翻译 | 示例
           

摘要

In the November issue (Vol. 29:31) of the Journal of Clinical Oncology, there are two "Comments and Controversies" published by our colleagues Dr Denis Chi, et al and Dr Ignace Vergote, et al. The topic of debate is the role of primary cytoreductive surgery versus neoadjuvant chemotherapy in advanced ovarian cancer.This heated discussion has been addressed in our publications for over three decades and has surfaced again recently due to the publication of the only prospective randomized clinical trial challenging this topic which was published in the NEJM on September 2, 2010.
机译:在《临床肿瘤学杂志》 11月号(第29:31卷)中,我们的同事Denis Chi博士等和Ignace Vergote博士等发表了两篇“评论和争议”。辩论的主题是原发性细胞减灭术与新辅助化疗在晚期卵巢癌中的作用。这一热烈的讨论在我们的出版物中已有三十多年的历史了,由于发表了唯一有挑战性的前瞻性随机临床试验,这一话题最近再次浮出水面。该主题发表在2010年9月2日的NEJM中。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号